[Image: masthead]

24-HOUR MH HOTLINE

800-644-9737

FOR EMERGENCIES ONLY

24-HOUR MH HOTLINE: 800-644-9737
FOR EMERGENCIES ONLY

Blog

Blog

Regular updates by our President, MHAUS staff, and guest contributors.

Honoring the Life of Professor Frank Lehmann-Horn
Guest Contributor
June 18, 2018
Open channels – The life of Prof. Dr. Dr. h.c. Dipl. Ing. Frank Lehmann-Horn   Prof. Dr. Dr. h.c. Dipl. Ing. Frank Lehmann-Horn, director of the department of applied physiology at Ulm university Germany from 1992 to 2010, passed away on May 8th, 2018 after suffering a severe disease …
Comments (0)
Heat and Exercise Induced Injury - Daniel Massik Essay Contest
MHAUS
March 22, 2018

The Malignant Hyperthermia Association of the United States (MHAUS) is pleased to announce the establishment of an award in the amount $1,500 to the primary author of a manuscript related to heat stroke or exercise-induced heat injury. 

Comments (1)
MH Readiness Feedback from Multiple Facilities
Dianne Daugherty, MHAUS Executive Director
April 17, 2017
The only requirement the Malignant Hyperthermia Association of the United States (MHAUS) will not waiver on is this:  Any facility using a trigger for malignant hyperthermia (potent volatile anesthetics and/or succinylcholine) must assure there is a sufficient supply of dantrolene sodium for injection available within 10 minutes, in whatever form …
Comments (1)
Intraoperative Presentation of MH Leads To KD Syndrome Diagnosis
MHAUS Staff
December 8, 2016
Abstract: We present the novel case report of a child with hypotonia and dysmorphic features who developed malignant hyperthermia (MH) intraoperatively. Neurology workup revealed the presence of a known causative ryanodine receptor (RYR1) mutation for MH, c.7522C>T; p.R2508C. Furthermore, the neurology workup diagnosed the child with King-Denborough syndrome (KDS). This …
Comments (0)
Honoring An MH Pioneer
Guest Contributor
November 15, 2016
Dr. Beverly Britt was a very significant contributor to important discoveries about malignant hyperthermia during her Professorship at the University of Toronto. Beverly was a dear friend of mine and was helpful to me as I started my career working with physicians; especially anesthesiologists.  Beverly died at her home in …
Comments (1)
CMS reported MH related deficiencies; are YOU ready?
MHAUS Staff
May 26, 2016
From 2011 through 2015, CMS inspection findings at various health systems revealed "deficiencies" related to MH preparedness.  ARE YOU READY FOR MH   Consider bringing one of MHAUS’ MH Experts to your facility to assure your plan of action is designed to address all areas of concern and you are …
Comments (0)
Survey of Long-Term Sequelae in Survivors of a Malignant Hyperthermia Reaction
Guest Contributor
April 6, 2016
Werneid, K., & Brandom, B. (2016). Survey of Long-Term Sequelae in Survivors of a Malignant Hyperthermia Reaction. Open Journal of Anesthesiology, 06(01), 1–7. http://doi.org/10.4236/ojanes.2016.61001 When researching malignant hyperthermia, there is ample information on causes, signs, symptoms, treatments, etc. Until now, there have been no studies examining any long term sequelae …
Comments (7)
Long Term Oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual
Guest Contributor
April 6, 2016
Butala, B. N., Kang, A., Guron, J., & Brandom, B. W. (2016). Long term oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual. Journal of Neuromuscular Diseases, 3(1), 115–119. http://doi.org/10.3233/JND-150130 A recent case report presented a patient with a significant family history of MH who had frequent symptoms …
Comments (2)
Malignant Hyperthermia: Colleagues of a Common Cause
Guest Contributor
March 29, 2016
Ramesh M. Singa MD, MHS; Cristina G. Pamaar MD Department of Anesthesiology and Perioperative Medicine, Saint Barnabas Medical Center, Livingston, NJ 07039 American and Filipino forces came together in Iloilo City, Philippines, on 8 January 2016. The group of healthcare professionals from the United States was led by Saint …
Comments (1)
From the OR to the ER: a case of MH
Guest Contributor
February 25, 2016
Reprinted with permission from Outpatient Surgery Magazine Marsha Thornhill, MD, the director of anesthesia at the Teaneck (N.J.) Surgical Center, helped save an 18-year-old patient’s life 7 years ago. The patient was having a rhinoplasty at a 1-room office-based plastic surgery center. The case was going very well, Dr. Thornhill …
Comments (2)
The New CHCT Equipment
Guest Contributor
January 25, 2016
Natalia Kraeva, PhD, MH investigation unit, Toronto, Canada The MHIU in Toronto, Canada has got a replacement for the CHCT apparatus, which had been used for the MH diagnosis for more than 35 years. The new MH measuring system, custom built for us by Biegler Medizinelektronik, Austria, fully complies …
Comments (1)
Eagle Pharmaceuticals Reports Successful Outcomes from Safety and Efficacy Study of RYANODEX for Exertional Heat Stroke
MHAUS Staff
January 21, 2016
Use of RYANODEX with Current Standard of Care (SOC) Showed Substantial Evidence of Increased Effectiveness in Treating EHS than SOC Alone Favorable Safety Data Shows No Significant Drug-Related Adverse Events in Patients Treated with RYANODEX Release Date: Thursday, December 17, 2015 6:50 am EST Dateline: WOODCLIFF LAKE, N.J. Public Company …
Comments (0)
Merck's BRIDION® (sugammadex) Receives FDA Approval
Guest Contributor
December 18, 2015
Merck’s BRIDION® (sugammadex) Receives FDA Approval for the Reversal of Neuromuscular Blockade Induced by Rocuronium and Vecuronium in Adults Undergoing Surgery KENILWORTH, N.J., Dec.17, 2015 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved …
Comments (0)
New Laboratory to Offer Genetic Testing for MH Susceptibility and Related Disorders
Dr. Geogirene Vladutiu, PhD
December 8, 2015
Genetic testing for susceptibility to Malignant Hyperthermia is already offered by a number of commercial laboratories (see the MHAUS web site for details). A new laboratory, the Robert Guthrie Biochemical and Molecular Genetics Laboratory at Buffalo General Medical Center, Buffalo, New York is now offering genetic testing for MH …
Comments (0)
New drug holds potential to reduce the use of a potent MH trigger drug
Dr. Henry Rosenberg MD, CPE
November 16, 2015
Succinylcholine (Anectine) is an MH trigger. Generally injected intravenously, the drug is usually used to produce deep muscle relaxation in order to facilitate such procedures as intubation of the trachea. The onset of relaxation is very rapid and the duration is generally less than 10 minutes. Succinylcholine, introduced in the …
Comments (0)
Henry Rosenberg, M.D., Named 2014 DSA Recipient
MHAUS Staff
September 21, 2015
Please read this wonderful article about Dr. Rosenberg, the President of MHAUS. Dr. Rosenberg is receiving an award this year at the American Society of Anethesiologists Annual Meeting. Join MHAUS in honoring Dr. Henry Rosenberg as he receives the ASA's Distinguished Service Award on October 24, 2015 in San Diego, …
Comments (2)
My Graduate Student Experience with the Nurse Anesthesia Program at UP
Guest Contributor
September 9, 2015
My name is Brooke DiIanni and I am a graduate student in the nurse anesthesia program at the University Pittsburgh.  As part of our didactic curriculum we are afforded the opportunity to work side by side with a researcher and become personally involved with a research entity. Malignant Hyperthermia (MH) …
Comments (1)
A Summary of a SRNA's Summer at the NAMHR of MHAUS
Guest Contributor
September 9, 2015
As an undergraduate, I participated as a research assistant for a study on dementia. It was mostly data entry and busy work. When we were told we had to volunteer for a research project as part of our research practicum, I thought it would be more data entry. A classmate …
Comments (0)
Report on the 34th Annual European MH Group meeting, June 10-12, 2015
Dr. Henry Rosenberg MD, CPE
June 29, 2015
The annual meeting of the European MH group took place in the charming city of Lille, France. About 80 physicians, scientists, students and clinicians who are studying the problem of malignant hyperthermia attended, giving 41 presentations. Attendees came from many countries inside and outside Europe including the Soviet Union, South …
Comments (1)
Ryanodine Receptor-1 (RYR1)Related Myopathy Research Study, 15-NR-0072 Volunteers Needed
Guest Contributor
May 22, 2015
The National Institute of Nursing Research (NINR) at the National Institutes of Health (NIH) in Bethesda, Maryland, is conducting a research study to determine if a drug that has been approved by the FDA for other indications reduces the severity of some symptoms in people with ryanodine receptor 1-related myopathy …
Comments (0)
The mission of MHAUS is to promote optimum care and
scientific understanding of MH and related disorders.